Good
Mostly Aligned
Patient Risk:
Low
Summary
Partially aligned: supported claims about prescription use for elevated triglycerides and triglyceride lowering were included, but several other claims are not supported by the provided label excerpts (notably familial hypercholesterolemia, HDL increase, and cost/discount/PAP details).
Category Scores
Accurate Statements
Vascepa is a prescription medication used to treat high triglycerides.
Supported by 1 INDICATIONS AND USAGE (adjunct to maximally tolerated statin therapy in adults with elevated triglyceride levels; adjunct to diet to reduce TG levels in severe hypertriglyceridemia).
Vascepa reduces triglyceride levels.
Supported by 1 INDICATIONS AND USAGE (adjunct to diet to reduce TG levels in severe hypertriglyceridemia; and adjunct to maximally tolerated statin therapy in elevated TG patients).
Unsupported Statements
Vascepa is prescribed for patients with familial hypercholesterolemia.
Not supported by the provided label excerpt (1 INDICATIONS AND USAGE does not mention familial hypercholesterolemia).
Vascepa increases levels of good cholesterol (HDL).
Not supported by the provided label excerpts. (12 CLINICAL PHARMACOLOGY is referenced in the scoring notes but no relevant content was provided in the excerpts.)
The average monthly cost of Vascepa is around $250.
Not supported by the provided label excerpts.
Amarin, the manufacturer of Vascepa, offers a patient assistance program that can help eligible patients save on their medication.
Not supported by the provided label excerpts.
Vascepa savings alerts can notify patients when discounts or promotions are available for Vascepa.
Not supported by the provided label excerpts.
GoodRx offers discounts on Vascepa.
Not supported by the provided label excerpts.
RxSaver offers discounts on Vascepa.
Not supported by the provided label excerpts.
Patient assistance programs (PAPs) provide financial assistance to eligible patients and can help patients save on Vascepa.
Not supported by the provided label excerpts.
The Patient Access Network Foundation offers a patient assistance program for Vascepa.
Not supported by the provided label excerpts.
CancerCare offers a patient assistance program for Vascepa.
Not supported by the provided label excerpts.
Discount cards, such as the Amarin Patient Assistance Program, can help save on Vascepa.
Not supported by the provided label excerpts.
Contradictions
Important Omissions
No dosage and administration details were evaluated because no claims included dosing instructions, and the provided label excerpts did not include a full DOSAGE AND ADMINISTRATION section to assess dosing-related claims.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
Only efficacy/indication-consistent claims were supported; unsupported claims were primarily about non-label financial/discount information and HDL/familial hypercholesterolemia, which are not safety-critical relative to the provided label excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
Several claims are not supported by the provided label excerpts (familial hypercholesterolemia, HDL increase, and cost/discount/PAP details).
Suggested Improvement
Restrict claims to the label-supported indications and triglyceride-lowering statements from 1 INDICATIONS AND USAGE; remove or qualify financial/discount/PAP and HDL/familial hypercholesterolemia assertions unless supported by the complete FDA label text.